EP Patent

EP2988729A1 — Pharmaceutical gastro-retentive solid oral dosage form of nilotinib

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-03-02 · 10y expired

What this patent protects

The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.

USPTO Abstract

The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
EP2988729A1
Jurisdiction
EP
Classification
—
Expires
2016-03-02
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.